Moreover, EVs shuttled miR-31-5p can transfer resistance information and promote sorafenib resistance in RCC by directly targeting MutL homolog 1, thereby both miR-31-5p and its target gene are likely to be predictive biomarkers and therapeutic targets for sorafenib resistance [32]. Here, MLH1 is linked to renal cell carcinoma.